Sign in

CIK 0001846253

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

OmniAb, Inc.

Sign in to watch
Ticker
OABI
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-250-7800
Business address
5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608
Former names
Avista Public Acquisition Corp. II

Securities

  • OABI Common Stock Nasdaq
  • OABIW Warrant Nasdaq
  1. 4 Grant or award Director acquired 53,308 shares (grant or award)
  2. 4/A Derivatives Options or other derivatives
  3. 4 Grant or award Director acquired 53,308 shares (grant or award)
  4. 4 Grant or award EVP, Finance and CFO acquired 139,504 shares (grant or award)
  5. 4 Grant or award Berkman Charles S acquired 46,864 shares (grant or award)
  6. 4 Grant or award President & CEO acquired 79,665 shares (grant or award)
  7. 4 Shares withheld for taxes Berkman Charles S gave up 6,518 shares (to pay taxes)
  8. 4 Shares withheld for taxes President & CEO gave up 11,624 shares (to pay taxes)
  9. 4 Open-market buy President & CEO bought 150,000 shares at $3.77 ($564,765)
  10. 4 Other disposition Director disposed of 15,817,934 shares (other)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Director bought 22,250 shares at $3.75 ($83,527)
  15. 4 Shares withheld for taxes Berkman Charles S gave up 10,580 shares (to pay taxes)
  16. 4 Shares withheld for taxes EVP, Finance and CFO gave up 6,733 shares (to pay taxes)
  17. 4 Derivatives Options or other derivatives
  18. 4 Shares withheld for taxes President & CEO gave up 17,266 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy President & CEO bought 300,000 shares at $3.39 ($1,016,340)

Page 7 of 9 · 174 filings